Colorectal Carcinogenesis and PFAS
Colorectal cancer (CRC) develops through progressive accumulation of mutations in colonic epithelial cells, promoted by chronic inflammation, gut microbiome dysbiosis, and exposure to genotoxic compounds. PFAS exposure creates multiple conditions favorable for CRC development: increased intestinal permeability, pro-inflammatory cytokine production in the colonic mucosa, and gut microbiome alterations that reduce protective short-chain fatty acid production.
PFAS also activate peroxisome proliferator-activated receptors (PPARα and PPARγ) in colonic epithelial cells. Aberrant PPAR activation in colon cells has been linked to altered cell proliferation and differentiation — early steps in carcinogenesis. Animal studies using colon cancer models show accelerated tumor development in PFAS-pre-treated animals.
Epidemiological Findings
A study of C8 Health Project participants — a large cohort with well-characterized PFOA exposure through contaminated water — found elevated colorectal cancer incidence in highly exposed community members. The association was stronger in men and showed a dose-response pattern consistent with causal relationship rather than chance finding.
Analyses of general population NHANES data have found associations between PFAS serum levels and colorectal adenoma (precancerous polyp) prevalence — an earlier endpoint than cancer that is detectable through colonoscopy. Higher PFAS levels correlated with more frequent adenomas, particularly in individuals over 50 years old.
Screening and Prevention
Gastroenterologists and primary care physicians in PFAS-contaminated communities should be aware of potentially elevated CRC risk in their patient populations. Standard screening protocols may need to consider earlier initiation or more frequent surveillance colonoscopy intervals in high-exposure individuals.
Diet-based CRC prevention strategies — high-fiber diets, reduced processed meat, adequate calcium and vitamin D — align well with measures to support gut health in PFAS-exposed individuals. Combined with drinking water filtration to reduce ongoing PFAS gut exposure, these interventions address both modifiable risk factors simultaneously.